Basilea Pharmaceutica AG
BPMUF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $580 | $419 | $570 | $437 |
| - Cash | $121 | $60 | $85 | $54 |
| + Debt | $112 | $129 | $187 | $219 |
| Enterprise Value | $571 | $488 | $672 | $602 |
| Revenue | $209 | $158 | $148 | $148 |
| % Growth | 32.3% | 6.7% | -0.2% | – |
| Gross Profit | $170 | $131 | $123 | $124 |
| % Margin | 81.5% | 83% | 83.3% | 83.7% |
| EBITDA | $66 | $23 | $22 | $4 |
| % Margin | 31.8% | 14.7% | 14.7% | 2.4% |
| Net Income | $78 | $10 | $12 | -$7 |
| % Margin | 37.2% | 6.6% | 8.2% | -4.6% |
| EPS Diluted | 5.83 | 0.86 | 1.02 | -0.58 |
| % Growth | 577.9% | -15.7% | 275.9% | – |
| Operating Cash Flow | $74 | $14 | $7 | -$32 |
| Capital Expenditures | -$2 | -$1 | -$3 | -$1 |
| Free Cash Flow | $73 | $13 | $4 | -$33 |